Understanding SGLT2 Inhibitors

Slideshow

This slideshow highlights several studies regarding the effects of SGLT2 inhibitors, which were presented at the 2016 ADA Scientific Sessions.

This slideshow highlights several studies regarding the effects of SGLT2 inhibitors, which were presented at the 2016 ADA Scientific Sessions.Session 3-CT-MPD17. SGLT2 Inhibitors-Understanding the Benefits and the Risks-And the Beat Goes On. ADA Scientific Sessions, New Orleans, LA. June 11, 2016. 

Related Videos
Laxmi Mehta, MD | Credit: American Heart Association
Reviewing 2023 with FDA Commissioner Robert M. Califf, MD
Erin Michos, MD | Credit: Johns Hopkins University
Natalie McCormick, PhD | Credit: American College of Rheumatology
Related Content
Stock imagery of diabetes related items. | Credit: Fotolia

ACP's New Type 2 Diabetes Guidance Recommends SGLT2is, GLP-1 RAs as Second-Line to Metformin

April 19th 2024
Article
Default thumbnail for Diabetes Dialogue, featuring podcast logo and headshots of hosts.

Diabetes Dialogue: 2024 ACP Type 2 Diabetes Recommendations

April 19th 2024
Podcast
Brendon Neuen, MBBS, PhD | Credit: X.Com

SMART-C Meta-Analysis: SGLT2 Inhibitors Reduce Cardiovascular Events

April 18th 2024
Article
Default thumbnail for Diabetes Dialogue, featuring podcast logo and headshots of hosts.

Diabetes Dialogue: STEP HFpEF DM and Fair Allocation of Incretin-Based Therapies

April 17th 2024
Podcast
Manufacturing Costs for Diabetes Medicines Could Likely Be Lower | Image Credit: Harvard University

Manufacturing Costs for Diabetes Medicines Could Likely Be Lower, Study Finds

April 4th 2024
Article
Endocrinology Month in Review: March 2024 thumbnail featuring HCOLive endocrinology logo

Endocrinology Month in Review: March 2024

April 3rd 2024
Article
© 2024 MJH Life Sciences

All rights reserved.